Adaptive Biotechnologies (ADPT) Income from Continuing Operations (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Income from Continuing Operations of 20015000.0 for Q1 2026, down 47.4% sequentially from 13579000.0 in Q4 2025, and up 32.9% YoY from 15059842.35 in Q1 2025.
Adaptive Biotechnologies (ADPT) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Income from Continuing Operations data on file, last reported at 20015000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 32.9% year-over-year to 20015000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 49642000.0 (up 65.01% YoY) and the FY2025 annual result came in at 59457000.0, up 62.75% from the prior year.
- Income from Continuing Operations fell to 20015000.0 in Q1 2026 per ADPT's latest filing, from 13579000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 9545000.0 in Q3 2025, with the low at 69467000.0 in Q4 2023.
- Average Income from Continuing Operations over 5 years is 39102294.12, with a median of 45319000.0 recorded in 2022.
- Year-over-year, Income from Continuing Operations slumped 72.94% in 2023 and surged 129.74% in 2025.
- Adaptive Biotechnologies' Income from Continuing Operations stood at 40169000.0 in 2022, then tumbled by 72.94% to 69467000.0 in 2023, then soared by 51.46% to 33717000.0 in 2024, then surged by 59.73% to 13579000.0 in 2025, then sank by 47.4% to 20015000.0 in 2026.
- Business Quant data shows ADPT's Income from Continuing Operations at 20015000.0 in Q1 2026, 13579000.0 in Q4 2025, and 9545000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -20.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.02 Mn |
| Dec 31, 2025 | -13.58 Mn |
| Sep 30, 2025 | 9.55 Mn |
| Jun 30, 2025 | -25.59 Mn |
| Mar 31, 2025 | -29.83 Mn |
| Dec 31, 2024 | -33.72 Mn |
| Sep 30, 2024 | -32.10 Mn |
| Jun 30, 2024 | -46.25 Mn |
| Mar 31, 2024 | -47.53 Mn |
| Dec 31, 2023 | -69.47 Mn |
| Sep 30, 2023 | -50.33 Mn |
| Jun 30, 2023 | -47.81 Mn |
| Mar 31, 2023 | -57.70 Mn |
| Dec 31, 2022 | -40.17 Mn |
| Sep 30, 2022 | -45.32 Mn |
| Jun 30, 2022 | -52.08 Mn |
| Mar 31, 2022 | -62.80 Mn |
| Dec 31, 2021 | -61.36 Mn |
| Sep 30, 2021 | -56.00 Mn |
| Jun 30, 2021 | -49.30 Mn |